Strategy + RehaCom for Memory Rehabilitation in Traumatic Brain Injury (TBI) (REHACOM-NJHF)

Kessler Foundation

Status: Unknown

Conditions: Traumatic Brain Injury With Loss of Consciousness

Treatments: Device: RehaCom (software)

Study type: Interventional

Funder types: Other

Identifiers

NCT04239456

E-1016-18

Details and patient eligibility

About

The purpose of this research study is to evaluate the effectiveness of "RehaCom," a computerized treatment for memory deficits, in a 16-session, interactive course. Following a manualized approach, the Rehacom modules will be used for the repeated application of the content acquired during 1-on-1 memory strategy training. The goal is to improve face/name, list and verbal memory of patients who survived a moderate to severe traumatic brain injury.

Full description

This randomized clinical trial (RCT) consists of 20 chronic moderate-to-severe TBI patients who will receive memory strategy training and complete three memory modules of the RehaCom at one of the Kessler Foundation locations. Changes in attention, processing speed, verbal/non-verbal new learning and memory (NLM) and executive control will be assessed via pre/post and 3-month follow-up assessments before and after the 8-10 week intervention. Self-report questionnaires will also track functional and emotional outcomes such as mood and anxiety, cognition, quality of life, self-efficacy, deficit awareness, community participation, and readiness for occupational functioning

Enrollment: 20 estimated patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Able to read and speak English fluently at the 5th grade level (for testing; software has multilingual support)
• Had a TBI at least 1 year ago
• No history of learning disorders during school years
• Able to use a personal computer (PC) non-stop for 1 hour without health or visual complaints; able to press keyboard buttons.No history of learning disorders

Exclusion criteria

• Actively participating in another intervention study
• Distance to Kessler Foundation East Hanover or West Orange location is more than 20 miles.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

20 participants in 2 patient groups

Group A

Experimental group

Description:

Receive intervention 2 weeks after group assignment.

Treatment:

Device: RehaCom (software)

Group B

Other group

Description:

Wait List - Receive intervention 3 months after initial testing.

Treatment:

Device: RehaCom (software)